Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05881993 · ClinicalTrials.gov registry record · Early Phase 1
Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects
A Early Phase 1 study of Healthy Volunteer Study, sponsored by Comanche Biopharma.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT05881993 is a Early Phase 1 study of Healthy Volunteer Study that has completed, run by Comanche Biopharma. The registered enrollment target is 45 participants, above the 31-participant average among 9 other Healthy Volunteer Study trials with a reported enrollment target (45% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05881993, a Early Phase 1 study of Healthy Volunteer Study, has completed, sponsored by Comanche Biopharma.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase I, first-in-human, single-center, randomized, double-blind, placebo-controlled, single ascending dose study to evaluate the safety, tolerability, and PK of ascending doses of CBP-4888.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG CBP-4888
Study Locations (1)
Texas
- Comanche Biopharma Clinical Research Site #1 - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-05-22 |
| Est. Completion | 2024-05-22 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05881993
The ClinicalTrials.gov registry entry for NCT05881993 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 31-participant average among 9 other Healthy Volunteer Study trials with a reported enrollment target (45% higher). The listed sponsor is Comanche Biopharma, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Volunteer Study appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05881993 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05881993 about?
NCT05881993 is a clinical study titled "Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects". This is a Phase I, first-in-human, single-center, randomized, double-blind, placebo-controlled, single ascending dose study to evaluate the safety, tolerability, and PK of ascending doses of CBP-4888.
What is the current status of trial NCT05881993?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 45 participants. The study started on 2023-05-22. Estimated completion is 2024-05-22.
What conditions does trial NCT05881993 study?
This clinical trial studies the following conditions: Healthy Volunteer Study.
What interventions are being tested in trial NCT05881993?
The interventions under investigation include: Placebo (OTHER), CBP-4888 (DRUG).
Who is sponsoring clinical trial NCT05881993?
This trial is sponsored by Comanche Biopharma, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05881993 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteer Study
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This Response
RECRUITING · Early Phase 1
-
Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function
RECRUITING · Phase 1
-
Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation
RECRUITING · Phase 1
-
Near-InfraRed Spectroscopy of Auricular Stimulation
RECRUITING · NA
-
A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects
COMPLETED · Phase 1
-
A Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 Formulations
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.